Keyword: Forest Laboratories
News
06.04.2016
- What a difference a day makes. On Apr. 3, European time, Pfizer and Allergan said the US Federal Trade Commission’s deeper probe into their potential merger, the so-called second...
News
07.04.2014
- Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...
News
08.08.2013
- Danish pharmaceuticals group Lundbeck posted a bigger-than-expected operating loss in the second quarter, hit by an EU fine for breaking competition law and cheap competition after...
News
20.06.2013
- Forest Laboratories, the specialty drugmaker that counts investor Carl Icahn as a major shareholder, is among a handful of companies interested in bidding for Irish drugmaker Elan...
News
23.05.2013
- Forest Laboratories said on Thursday that Howard Solomon, who has led the biotech firm since 1977, will retire as chief executive officer at the end of this year and the company...
News
03.04.2013
- Shares of Optimer Pharmaceuticals rose as much as 24% after a Bloomberg report said GlaxoSmithKline and Cubist Pharmaceuticals were among those interested in buying the antibiotic...
News
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
News
15.01.2013
- Forest Laboratories posted an unexpectedly large loss in its fiscal third quarter as sales of its antidepressant Lexapro were buffeted by generic competition and sales of its...
